logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Pharmasset, Inc.


USPTO Granted Patents = 19



Forward Citations = 914

Loading Chart...
Loading Chart...

32 inventors (with patents filed for the assignee):

goldMedal Junxing Shi (8 out of 23 patents)

silverMedal Kyoichi A Watanabe (8 out of 10 patents)

bronzeMedal Michael J Otto (6 out of 10 patents)

4.  Raymond F Schinazi (4 out of 124 patents)

5.  Peiyuan Wang (3 out of 47 patents)

6.  Lieven Stuyver (3 out of 4 patents)

7.  Jinfa Du (3 out of 34 patents)

8.  Byoung-Kwon Chun (2 out of 27 patents)

9.  Erik Alan Gustafson (2 out of 7 patents)

10.  Joyce D Fingeroth (2 out of 3 patents)

11.  Krystyna Lesiak (2 out of 7 patents)

12.  Krzysztof W Pankiewicz (2 out of 2 patents)

13.  Abel De La Rosa (1 out of 15 patents)

14.  Pasquale N Confalone (1 out of 25 patents)

15.  Michael Joseph Sofia (1 out of 34 patents)


19 patents:

1. 8735345 - Therapeutic composition (2014-05-27),
2. 8114997 - [object Object] (2012-02-14),
3. 8093380 - [object Object] (2012-01-10),
4. 7964580 - Nucleoside phosphoramidate prodrugs (2011-06-21),
5. 7919247 - Simultaneous quantification of nucleic acids in diseased cells (2011-04-05),
6. RE42015 - N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections (2010-12-27),
7. 7772208 - [object Object] (2010-08-10),
8. 7718790 - Kit for assessing mitochondrial toxicity (2010-05-18),
9. 7638502 - Treatment of EBV and KHSV infection and associated abnormal cellular proliferation (2009-12-29),
10. 7601820 - Preparation of alkyl-substituted 2-deoxy-2-fluoro-D-ribofuranosyl pyrimidines and purines and their derivatives (2009-10-13),
11. 7429572 - Modified fluorinated nucleoside analogues (2008-09-30),
12. 7211570 - Treatment of EBV and KHSV infection (2007-05-01),
13. 7094770 - 3'-or 2′-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections (2006-08-22),
14. 6949522 - β-2'- or 3′-halonucleosides (2005-09-27),
15. 6927291 - Method for the synthesis of 2',3′-dideoxy-2′,3′-didehydronucleosides (2005-08-09),
Pharmasset, Inc. is a biopharmaceutical company specializing in the discovery and development of antiviral therapies. Their mission is to advance the treatment of viral infections, including hepatitis C. Through innovative research and development, Pharmasset aims to develop safe and effective therapies that improve patients' lives worldwide.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#46 in Princeton, NJ

#646 in New Jersey

#16,629 in US

#31,713 in the World

...
Princeton, NJ, United States of America

Pharmasset, Inc.

Forward Citations = 914

32 inventors:

goldMedal Junxing Shi (8 out of 23 patents)

silverMedal Kyoichi A Watanabe (8 out of 10 patents)

bronzeMedal Michael J Otto (6 out of 10 patents)

4.  Raymond F Schinazi (4 out of 124 patents)

5.  Peiyuan Wang (3 out of 47 patents)

Please report any incorrect information to support@idiyas.com
Loading…